Applied Dna Sciences (NASDAQ:BNBX) Releases Quarterly Earnings Results

Applied Dna Sciences (NASDAQ:BNBX) posted its quarterly earnings data on Friday. The company reported ($0.68) EPS for the quarter, Zacks reports.

Applied Dna Sciences Stock Down 6.4%

NASDAQ BNBX traded down $0.03 on Friday, reaching $0.44. The company had a trading volume of 51,726 shares, compared to its average volume of 1,940,461. Applied Dna Sciences has a 52-week low of $0.44 and a 52-week high of $12.09. The business has a fifty day moving average price of $0.62. The stock has a market capitalization of $2.49 million, a PE ratio of 0.00 and a beta of 0.58.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Applied Dna Sciences in a report on Friday, April 24th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

About Applied Dna Sciences

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.